SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-105199
Filing Date
2021-04-02
Accepted
2021-04-02 16:48:02
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFA14A d19975ddefa14a.htm DEFA14A 50452
2 GRAPHIC g1997519d1.jpg GRAPHIC 65453
3 GRAPHIC g19975na3.jpg GRAPHIC 2378
4 GRAPHIC g19975na4.jpg GRAPHIC 2840
5 GRAPHIC g19975na5.jpg GRAPHIC 885
6 GRAPHIC g19975newcontrl.jpg GRAPHIC 13976
  Complete submission text file 0001193125-21-105199.txt   169907
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Filer) CIK: 0001178670 (see all company filings)

IRS No.: 770602661 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36407 | Film No.: 21802564
SIC: 2834 Pharmaceutical Preparations